Biochemical Medicine and Metabolic Biology 1992-06-01

Inhibitory effect of demoxepam on tryptophan binding to rat hepatic nuclei.

H Sidransky, E Verney, J W Cosgrove, A M Schwartz

Index: Biochem. Med. Metab. Biol. 47(3) , 270-3, (1992)

Full Text: HTML

Abstract

Since some patients with eosinophilia-myalgia syndrome ingested tryptophan along with benzodiazepines, we investigated whether demoxepam, the N-desalkylated compound of chlordiazepoxide, would influence the binding of tryptophan to hepatic nuclei. L-Tryptophan has been shown to bind (saturable, stereospecific, and of high affinity) to rat hepatic nuclei and nuclear envelopes. We report that demoxepam has an inhibitory effect on in vitro [3H]tryptophan binding to rat hepatic nuclei and has an apparent KD approximately 22 microM.

Related Compounds

  • Demoxepam

Related Articles:

Liquid chromatography of demoxepam and phenothiazines using a post-column photochemical reactor and fluorescence detection.

[J. Chromatogr. A. 217 , 463-71, (1981)]

The rapid hydrolysis of chlordiazepoxide to demoxepam may affect the outcome of chronic osmotic minipump studies.

2010-03-01

[Psychopharmacology 208(4) , 555-62, (2010)]

Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the rat.

[J. Chromatogr. A. 277 , 201-8, (1983)]

Assay of chlordiazepoxide and demoxepam in chlordiazepoxide formulations by difference spectrophotometry.

1984-01-01

[J. Pharm. Sci. 73(1) , 55-8, (1984)]

Pharmacokinetic studies on Ro 15-1788, a benzodiazepine receptor ligand, in the brain of the rat.

1984-01-02

[Brain Res. 290(1) , 183-6, (1984)]

More Articles...